Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: exertional angina major surgical or invasive procedure: cabg x4 (lima to lad, svg to ramus, svg to om, svg to pda) history of present illness: 70 yo female with exertional angina and + stress echo revealing anterior ischemia. cath revealed severe 3 vessel cad. referred for surgery. past medical history: coronary artery disease obesity prior inferior myocardial infarction insulin-dependent diabetes mellitus hypertension diabetic retinopathy hypothyroidism gastroesophageal reflux disease hyperlipidemia social history: retired teacher and librarian lives with son 4 pk-yr hx/ quit 48 years ago no etoh family history: father died of mi at 65;mother died of mi at 61 physical exam: ht 61" wt 94.3k discharge exam: vs t98.7 bp 156/80 hr 73sr rr 20 o2sat 95%ra wt 94.4k gen nad neuro a&ox3, nonfocal exam pulm scattered rhonchi cv rrr, no murmur. sternum stable, incision cdi abdm soft, nt/+bs ext warm well perfused. 1+ pedal edema bilat pertinent results: conclusions pre-bypass: 1. the left atrium is normal in size. no atrial septal defect is seen by 2d or color doppler. 2. left ventricular wall thicknesses and cavity size are normal. there is moderate regional left ventricular systolic dysfunction with anterior, septal and antero-lateral hypokinesis from the mid to apex segments. overall left ventricular systolic function is moderately depressed (lvef= 35 %). 3. right ventricular chamber size and free wall motion are normal. 4. there are three aortic valve leaflets. the aortic valve leaflets are mildly thickened. there is no aortic valve stenosis. no aortic regurgitation is seen. 5. the mitral valve leaflets are mildly thickened. mild to moderate (+) mitral regurgitation is seen. 6. there is no pericardial effusion. dr. was notified in person of the results. post-bypass: for the post-bypass study, the patient was receiving vasoactive infusions including phenylephrine and was initially av paced. 1. bi ventricular function is unchanged. 2. mr initially severe with av pacing, improved to mild with a pacing. 3. aorta is intact post decannulation. 4. other findings are unchanged. radiology report chest (portable ap) study date of 3:33 pm medical condition: 70 year old woman s/p cabg reason for this examination: please eval for pneumo now s/p left pleural chest tube removal provisional findings impression: sp tue 7:07 pm pfi: no pneumothorax after chest tube removal, stable chest findings. final report findings: ap single view of the chest obtained with patient in semi-erect position is analyzed in direct comparison with a preceding similar study obtained approximately four hours earlier during the same day. during the interval, the left-sided chest tube has been removed. no pneumothorax has developed. there is no evidence of increased density in the lower pleural space in comparison with the preceding study and no new pulmonary parenchymal infiltrates have developed. impression: stable chest findings, no pneumothorax after left-sided chest tube removal. dr. approved: tue 9:01 pm 03:11pm urea n-19 creat-0.8 chloride-110* total co2-26 03:11pm wbc-25.0*# rbc-3.41* hgb-9.9* hct-29.6* mcv-87 mch-29.2 mchc-33.6 rdw-13.6 03:11pm plt count-312 03:11pm pt-13.8* ptt-47.0* inr(pt)-1.2* 01:45pm glucose-202* lactate-3.6* na+-133* k+-5.5* cl--105 05:22am blood wbc-13.6* rbc-2.77* hgb-8.1* hct-24.4* mcv-88 mch-29.1 mchc-33.1 rdw-14.1 plt ct-282 01:40pm blood wbc-14.7*# rbc-2.86*# hgb-8.2*# hct-24.8* mcv-87 mch-28.8 mchc-33.3 rdw-13.7 plt ct-297 05:22am blood glucose-103 urean-44* creat-1.1 na-135 k-5.1 cl-101 hco3-27 angap-12 04:00am blood glucose-80 urean-24* creat-1.1 na-138 k-5.3* cl-109* hco3-23 angap-11 brief hospital course: same day admission to operating room for cabg. admitted on and underwent surgery with dr. . please refer to dr operative report for details. in summary she had coronary artery bypass grafting x4 with lima-lad, svg-om, svg-ramus, svg-pda. she tolerated the operation well and and following surgery was transferred to the cvicu in stable condition. she remained hemodynamically stable in the immediate post-op period was titrated off phenylephrine, propofol and insulin drips, and extubated later that evening. all lines and drains were discontinued per protocol. on pod#2 she transferred to step down unit for further monitoring and telemetry. her creatinine was mildly elevated but returned to baseline over the next several days. beta-blockers and ace were initiated and plavix restarted. her activity level continued to progress and on pod #4 she was discharged to rehab at . all follow up appointments are oulined on discharge paperwork. medications on admission: plavix 75 mg daily (ld ) humalog 50 units q am; 28 units qhs hctz 25 mg daily levothyroxine 150 mcg daily ecasa 81 mg daily lisinopril 40 mg daily zetia 10 mg daily niaspan 100 mg daily discharge medications: 1. potassium chloride 10 meq tablet sustained release sig: two (2) tablet sustained release po once a day for 2 weeks. disp:*28 tablet sustained release(s)* refills:*0* 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 3. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 4. levothyroxine 150 mcg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*2* 5. ezetimibe 10 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 6. niacin 1,000 mg tablet sustained release sig: one (1) tablet sustained release po once a day. disp:*30 tablet sustained release(s)* refills:*2* 7. acetaminophen 325 mg tablet sig: two (2) tablet po q4h (every 4 hours) as needed. 8. insulin lispro 100 unit/ml solution sig: as directed subcutaneous twice a day: 50 units qam 28 units qpm. 9. clopidogrel 75 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 10. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po every 4-6 hours as needed for pain. disp:*50 tablet(s)* refills:*0* 11. metoprolol tartrate 50 mg tablet sig: one (1) tablet po twice a day. disp:*60 tablet(s)* refills:*2* 12. lisinopril 10 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 13. furosemide 40 mg tablet sig: one (1) tablet po once a day for 2 weeks. disp:*14 tablet(s)* refills:*0* 14. ranitidine hcl 150 mg tablet sig: one (1) tablet po daily (daily). 15. magnesium hydroxide 400 mg/5 ml suspension sig: thirty (30) ml po hs (at bedtime) as needed for constipation. discharge disposition: extended care facility: - discharge diagnosis: cad s/p cabg x4 obesity prior inferior myocardial infarction insulin-dependent diabetes mellitus hypertension diabetic retinopathy hypothyroidism gastroesophageal reflux disease hyperlipidemia discharge condition: good discharge instructions: no lotions, creams or powders on any incision shower daily and pat incisions dry no lifting greater than 10 pounds for 10 weeks no driving for one month and until off all narcotics call for fever greater than 100.5, redness or drainage followup instructions: see dr. in weeks see dr. in weeks see dr. in 4 weeks please call for appts. procedure: (aorto)coronary bypass of three coronary arteries single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery transfusion of packed cells diagnoses: obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery esophageal reflux pure hypercholesterolemia unspecified essential hypertension unspecified acquired hypothyroidism atrial fibrillation other specified forms of chronic ischemic heart disease other and unspecified angina pectoris long-term (current) use of insulin old myocardial infarction obesity, unspecified diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy 

Answer: The patient is high likely exposed to